Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 7Sarcoma 3Liposarcoma, Myxoid 3Sarcoma, Synovial 2Prostatic Neoplasms 2Neurofibrosarcoma 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Fibrosarcoma 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Thymoma 1Small Cell Lung Cancer Limited Stage 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Radiotherapy; Complications 1Radiation Injuries 1Neoplasm Metastasis 1Myosarcoma 1Lymphangiosarcoma 1Lung Neoplasms 1Limited Stage Small Cell Lung Cancer 1Hyperthermia 1Histiocytic Sarcoma 1Endometrial Neoplasms 1Dermatofibrosarcoma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Carcinoma In Situ 1

Interventions

130-nm albumin-bound paclitaxel 2selinexor 1pembrolizumab 1isophosphamide mustard 1epacadostat 1Sunitinib 1Ramucirumab 1Radiotherapy 1Radiation Dose Hypofractionation 1Paclitaxel 1Leucovorin 1Histocompatibility Testing 1Granulocyte-Macrophage Colony-Stimulating Factor 1Epirubicin 1Cyclophosphamide 1Cisplatin 1Chemoradiotherapy 1Carboplatin 168Ga-pentixafor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Thymoma × Radiation Dose Hypofractionation × Clear all
NCT03663764 2021-12-10

Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor

Sun Yat-sen University

Phase 2 Unknown
57 enrolled
Thoracic

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡